Cardiac Resynchronization Therapy Market - Global Industry Analysis

The global Cardiac Resynchronization Therapy market, which amassed revenue worth nearly 4.3 (USD Billion) in 2019, will register a CAGR of nearly 4.8% during the period from 2020 to 2026. The report offers assessment and analysis of the Cardiac Resynchronization Therapy market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, sales estimates, opportunities, evolving trends, and industry-validated data. The report offers historical data from 2017 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion).

Details of the Report:

Introduction

Cardiac resynchronization treatment was launched at the end of twentieth century. It has brought a paradigm shift in the medical treatment and has proved a boon for patients with systolic heart failure symptoms. The key objective of the cardiac resynchronization therapy is restoring of mechanical synchrony through electric activation of heart in a synchronized way. Clinical trials have demonstrated favorable outcomes when the patients exhibiting the heart failure symptoms are given combined cardiac resynchronization & medical treatment. Moreover, these combined treatments not only diminishes heart failure hospitalizations but also minimizes rate of mortality along with enhancing quality of life of patients. `

Market Growth Dynamics

Cardiac resynchronization treatment has brought revolutionary changes in the patient care sector and this will boost the market growth over the upcoming years. With CRT or cardiac resynchronization therapy established as device treatment for heart failure patients, the cardiac resynchronization therapy industry is likely to gain traction over the forthcoming years. Apart from this, current know-how of implantation procedures, breakthroughs in device-based systems, and successful clinical trial outcomes    has notably influenced the expansion of the cardiac resynchronization therapy business in the recent years.

Furthermore, the therapy has proved to be an effective tool for treating patients with refractory heart failure symptoms, patients with serious left ventricle systolic dysfunctioning, and intraventricular conduction delay. CRT improves exercise tolerance and minimizes LV dilation, thereby proliferating market growth. According to studies conducted by NIH researchers, cardiac resynchronization treatment has resulted in reduction in proinflammatory and neurohormonal biomarkers. It also helps in enhancing heart pump proficiency and restoring ventricular contraction synchrony along with improving heart stole volume as well as LV contraction & ejection fraction. The main aim of the cardiac resynchronization treatment is maintaining interventricular & intraventricular synchrony. Apparently, introduction of novel cardiac resynchronization treatment systems along with growing trend of using wireless cardiac resynchronization therapy systems as well as adaptive optimization of CRT programming & multipoint pacing are predicted to influence the growth of cardiac resynchronization therapy market in the next decade.

Asia Pacific Market To Record Highest Growth Rate Over 2020-2026

The growth of the industry in Asia Pacific continent over the assessment period is due to surge in the heart disorders and improvement in the healthcare services in various countries of the region. Apart from this, favorable medical health insurance policies in the countries like Japan and India will further prompt the regional market trends.

Key players profiled in the report include Boston Scientific Corporation, Abbott, Medico S.p.A., Medtronic, MicroPort Scientific Corporation, and BIOTRONIK.

The global cardiac resynchronization therapy market is segmented as follows:

By Product Type

• Cardiac Resynchronization Therapy Defibrillators
• Cardiac Resynchronization Therapy Pacemakers

By End User

• Hospitals & Cardiac Centers
• Ambulatory Surgery Centers

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

• Chapter 1. Preface
  • 1.1. Report Description and Scope
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology
• Chapter 2. Executive Summary
  • 2.1. Cardiac Resynchronization Therapy Market, 2016–2026(USD Billion)
  • 2.2. Cardiac Resynchronization Therapy Market: Snapshot
• Chapter 3. Global Cardiac Resynchronization Therapy Market– Industry Analysis
  • 3.1. Cardiac Resynchronization Therapy Market: Market Dynamics
  • 3.2. Market Drivers
    • 3.2.1. CRT improves exercise tulerance and minimizes LV dilation, thereby pruliferating market growth.
    • 3.2.2. Launching of novel cardiac resynchronization treatment systems along with growing trend of using wireless cardiac resynchronization therapy systems as well as adaptive optimization of CRT programming & multipoint pacing are predicted to influence the growth of cardiac resynchronization therapy market within the next few years.
  • 3.3. Market Attractiveness Analysis
    • 3.3.1. Market attractiveness analysis By Product Type
    • 3.3.2. Market attractiveness analysis By End-User
• Chapter 4. Global Cardiac Resynchronization Therapy Market– Competitive Landscape
  • 4.1. Company market share analysis
    • 4.1.1. Global Cardiac Resynchronization Therapy Market: company market share, 2019
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New Product launches
    • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
    • 4.2.4. Research and development and Regional expansion
  • 4.3. Price trend analysis
• Chapter 5. Global Cardiac Resynchronization Therapy Market–Product Type Analysis
  • 5.1. Global Cardiac Resynchronization Therapy Market overview: By Product Type
    • 5.1.1. Global Cardiac Resynchronization Therapy Market share, By Product Type,2019 and 2026
  • 5.2. CARDIAC RESYNCHRONIZATION THERAPY PACEMAKER
    • 5.2.1. Global Cardiac Resynchronization Therapy Market by CARDIAC RESYNCHRONIZATION THERAPY PACEMAKER, , 2016–2026(USD Billion)
  • 5.3. CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR
    • 5.3.1. Global Cardiac Resynchronization Therapy Market by CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR, 2016–2026(USD Billion)
• Chapter 6. Global Cardiac Resynchronization Therapy Market– End-User Analysis
  • 6.1. Global Cardiac Resynchronization Therapy Market overview: By End-User
    • 6.1.1. Global Cardiac Resynchronization Therapy Market share, By End-User , 2019 and 2026
  • 6.2. Ambulatory Surgery Centers
    • 6.2.1. Global Cardiac Resynchronization Therapy Market by Ambulatory Surgery Centers , 2016–2026(USD Billion)
  • 6.3. Hospitals & Cardiac Centers
    • 6.3.1. Global Cardiac Resynchronization Therapy Market by Hospitals & Cardiac Centers, 2016–2026(USD Billion)
• Chapter 7. Company Profiles
  • 7.1. Abbot
    • 7.1.1. Overview
    • 7.1.2. Financials
    • 7.1.3. Product Portfolio
    • 7.1.4. Business Strategy
    • 7.1.5. Recent Developments
  • 7.2. Medtronic
    • 7.2.1. Overview
    • 7.2.2. Financials
    • 7.2.3. Product Portfolio
    • 7.2.4. Business Strategy
    • 7.2.5. Recent Developments
  • 7.3. MicroPort Scientific Corporation
    • 7.3.1. Overview
    • 7.3.2. Financials
    • 7.3.3. Product Portfolio
    • 7.3.4. Business Strategy
    • 7.3.5. Recent Developments
  • 7.4. Boston Scientific Corporation
    • 7.4.1. Overview
    • 7.4.2. Financials
    • 7.4.3. Product Portfolio
    • 7.4.4. Business Strategy
    • 7.4.5. Recent Development
  • 7.5. Medico S.p.A.
    • 7.5.1. Overview
    • 7.5.2. Financials
    • 7.5.3. Product Portfolio
    • 7.5.4. Business Strategy
    • 7.5.5. Recent Development
  • 7.6. BIOTRONIK
    • 7.6.1. Overview
    • 7.6.2. Financials
    • 7.6.3. Product Portfolio
    • 7.6.4. Business Strategy
    • 7.6.5. Recent Development

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Cardiac Resynchronization Therapy Market, 2016–2026(USD Billion)
4. Porter’s Five Forces Analysis
5. Global Cardiac Resynchronization Therapy Market attractiveness, By Product Type 
6. Global Cardiac Resynchronization Therapy Market attractiveness, By End-User  
7. Global Cardiac Resynchronization Therapy Market share, By Product Type , 2019 and 2026 (USD Billion)
8. Global Cardiac Resynchronization Therapy Market by CARDIAC RESYNCHRONIZATION THERAPY PACEMAKER, 2016–2026(USD Billion)
9. Global Cardiac Resynchronization Therapy Market by CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR,2016–2026(USD Billion)
10. Global Cardiac Resynchronization Therapy Market share by End-User  ,2019 and 2026 (USD Billion)
11. Global Cardiac Resynchronization Therapy Market by Ambulatory Surgery Centers , 2016–2026(USD Billion)
12. Global Cardiac Resynchronization Therapy Market by Hospitals & Cardiac Centers, 2016–2026(USD Billion)
13. Global Cardiac Resynchronization Therapy Market share, by Region, 2019 and 2026
14. North America Cardiac Resynchronization Therapy Market, 2016–2026(USD Billion)
15. Europe Cardiac Resynchronization Therapy Market, 2016–2026(USD Billion)
16. Asia Pacific Cardiac Resynchronization Therapy Market, 2016–2026(USD Billion)
17. Latin America Cardiac Resynchronization Therapy Market, 2016–2026(USD Billion)
18. The Middle East and Africa Cardiac Resynchronization Therapy Market, 2016–2026(USD Billion)

Table Of Tables

List of Tables

1. Global Cardiac Resynchronization Therapy Market: snapshot
2. Drivers of the Cardiac Resynchronization Therapy Market: impact analysis
3. North America Cardiac Resynchronization Therapy Market revenue, By Product Type ,2016–2026(USD Billion)
4. North America Cardiac Resynchronization Therapy Market revenue, By End-User, 2016–2026(USD Billion)
5. The U.S. Cardiac Resynchronization Therapy Market revenue, By Product Type , 2016–2026(USD Billion)
6. The U.S. Cardiac Resynchronization Therapy Market revenue, By End-User  , 2016–2026(USD Billion)
7. Rest of North America Cardiac Resynchronization Therapy Market revenue, By Product Type ,2016–2026(USD Billion)
8. Rest of North America Cardiac Resynchronization Therapy Market revenue, By End-User  , 2016–2026(USD Billion)
9. Europe Cardiac Resynchronization Therapy Market revenue, By Product Type , 2016–2026(USD Billion)
10. Europe Cardiac Resynchronization Therapy Market revenue, By End-User  , 2016–2026(USD Billion)
11. UK Cardiac Resynchronization Therapy Market revenue, By Product Type ,2016–2026(USD Billion)
12. UK Cardiac Resynchronization Therapy Market revenue, By End-User  , 2016–2026(USD Billion)
13. France Cardiac Resynchronization Therapy Market revenue, By Product Type ,2016–2026(USD Billion)
14. France Cardiac Resynchronization Therapy Market revenue, By End-User  , 2016–2026(USD Billion)
15. Germany Cardiac Resynchronization Therapy Market revenue, By Product Type ,2016–2026(USD Billion)
16. Germany Cardiac Resynchronization Therapy Market revenue, By End-User  , 2016–2026(USD Billion)
17. Rest of Europe Cardiac Resynchronization Therapy Market revenue, By Product Type ,2016–2026(USD Billion)
18. Rest of Europe Cardiac Resynchronization Therapy Market revenue, By End-User  , 2016–2026(USD Billion)
19. Asia Pacific Cardiac Resynchronization Therapy Market revenue, By Product Type ,2016–2026(USD Billion)
20. Asia Pacific Gene Editing  , By End-User , 2016–2026(USD Billion)
21. China Cardiac Resynchronization Therapy Market revenue, By Product Type ,2016–2026(USD Billion)
22. China Cardiac Resynchronization Therapy Market revenue, By End-User  , 2016–2026(USD Billion)
23. Japan Cardiac Resynchronization Therapy Market revenue, By Product Type , 2016–2026(USD Billion)
24. Japan Cardiac Resynchronization Therapy Market revenue, By End-User  , 2016–2026(USD Billion)
25. India Cardiac Resynchronization Therapy Market revenue, By Product Type  ,2016–2026(USD Billion)
26. India Cardiac Resynchronization Therapy Market revenue, By End-User  , 2016–2026(USD Billion)
27. Rest of Asia Pacific Cardiac Resynchronization Therapy Market revenue, By Product Type ,2016–2026(USD Billion)
28. Rest of Asia Pacific Cardiac Resynchronization Therapy Market revenue, By End-User  , 2016–2026(USD Billion)
29. Latin America Cardiac Resynchronization Therapy Market revenue, By Product Type ,2016–2026(USD Billion)
30. Latin America Cardiac Resynchronization Therapy Market revenue, By End-User , 2016–2026(USD Billion)
31. Brazil Cardiac Resynchronization Therapy Market revenue, By Product Type ,2016–2026(USD Billion)
32. Brazil Cardiac Resynchronization Therapy Market revenue, By End-User , 2016–2026(USD Billion)
33. Rest of Latin America Cardiac Resynchronization Therapy Market revenue, By Product Type ,2016–2026(USD Billion)
34. Rest of Latin America Cardiac Resynchronization Therapy Market revenue, By End-User  , 2016–2026(USD Billion)
35. The Middle East and Africa Cardiac Resynchronization Therapy Market revenue, By Product Type ,2016–2026(USD Billion)
36. The Middle East and Africa Cardiac Resynchronization Therapy Market revenue, By End-User  , 2016–2026(USD Billion)
37. Saudi Arabia Cardiac Resynchronization Therapy Market revenue, By Product Type , 2016–2026(USD Billion)
38. Saudi Arabia Cardiac Resynchronization Therapy Market revenue, By End-User  , 2016–2026(USD Billion)
39. South Africa Cardiac Resynchronization Therapy Market revenue, By Product Type ,2016–2026(USD Billion)
40. South Africa Cardiac Resynchronization Therapy Market revenue, By End-User  , 2016–2026(USD Billion)
41. Rest of the Middle East & Africa Cardiac Resynchronization Therapy Market revenue, By Product Type ,2016–2026(USD Billion)
42. Rest of the Middle East & Africa Cardiac Resynchronization Therapy Market revenue, By End-User  , 2016–2026(USD Billion)